z-logo
open-access-imgOpen Access
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
Author(s) -
Philip L. McCarthy,
Kouros Owzar,
Craig C. Hofmeister,
David D. Hurd,
Hani Hassoun,
Paul G. Richardson,
Sergio Giralt,
Edward A. Stadtmauer,
Daniel J. Weisdorf,
Ravi Vij,
Jan S. Moreb,
Natalie S. Callander,
Koen van Besien,
Teresa Gentile,
Luis Isola,
Richard T. Maziarz,
Don A. Gabriel,
Asad Bashey,
Heather Landau,
T. John Martin,
Muzaffar H. Qazilbash,
Denise Levitan,
Brian McClune,
Robert Schlossman,
Vera Hárs,
John Postiglione,
Chen Jiang,
Elizabeth L. Bennett,
Susan R. Barry,
Linda R. Bressler,
Michael Kelly,
Michele Seiler
Publication year - 2012
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - Uncategorized
DOI - 10.17615/0rke-xe60
Subject(s) - lenalidomide , multiple myeloma , transplantation , autologous stem cell transplantation , stem cell , medicine , oncology , cancer research , biology , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom